Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Point Therapeutics Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Point Therapeutics Inc since year 2005.
Table 2 shows the detailed insider transactions of Point Therapeutics Inc since 2005.
The reporting company's ticker symbol is POTP. The reporting company's CIK number is 919745.
The total value of stock buying since 2005 is $324,536.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $210,750.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2013-06-03||Clement Christopher G (President)||Buy||14,000||.71||9,982|
|2013-05-30||Cochrane Haywood D (Director)||Buy||10,000||.70||7,000|
|2013-05-23||Heady Timothy James (Director)||Buy||10,000||.75||7,480|
|2013-05-17||Drutz David (CEO and CMO)||Buy||25,000||.70||17,450|
|2012-09-17||Drutz David (CEO and CMO)||Buy||25,000||1.06||26,500|
|2012-09-11||Cochrane Haywood D (Director)||Buy||2,800||.82||2,296|
|2012-09-10||Cochrane Haywood D (Director)||Buy||2,200||.78||1,716|
|2012-07-20||Cochrane Haywood D (Director)||Buy||9,000||.73||6,579|
|2012-07-19||Cochrane Haywood D (Director)||Buy||1,000||.74||745|
|2012-06-08||Drutz David (CEO and CMO)||Buy||25,000||.77||19,250|
|2012-05-29||Drutz David (CEO and CMO)||Buy||25,000||.90||22,525|
|2011-04-26||Franco Richard A (President & CEO)||Buy||3,500||2.78||9,730|
|2010-09-02||Franco Richard A (President & CEO)||Buy||5,000||2.64||13,200|
|2010-08-31||Franco Richard A (President & CEO)||Buy||5,000||2.29||11,450|
|2010-05-24||Franco Richard A (President & CEO)||Buy||2,000||4.18||8,360|
|2010-05-20||Franco Richard A (President & CEO)||Buy||1,000||4.45||4,450|
|2010-05-19||Franco Richard A (President & CEO)||Buy||3,096||3.85||11,919|
|2010-02-11||Franco Richard A (President & CEO)||Option Ex||400,000||.25||100,000|
|2009-09-24||Rosar Ann A (Chief Accounting Officer)||Option Ex||25,000||.43||10,750|
|2009-09-24||Franco Richard A (President & CEO)||Option Ex||400,000||.25||100,000|
|2008-02-22||Didsbury John (Chief Scientific Officer)||Buy||9,000||2.34||21,024|
|2008-02-22||Franco Richard A (Chairman, President and CEO)||Buy||10,200||1.90||19,380|
|2005-11-21||Barberich Timothy J (Chief Executive Officer)||Buy||34,500||3.00||103,500|
Insider trading activities including stock purchases, stock sales, and option exercises of POTP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Point Therapeutics Inc (symbol POTP, CIK number 919745) see the Securities and Exchange Commission (SEC) website.